EV/EBITDA:
-18.61+0.77(+3.97%)Summary
- As of today (July 27, 2025), AXSM EV/EBITDA is -18.61, with a rise of +0.77 (+3.97%) during the most recent trading session on July 25, 2025.
- Over the past year, AXSM EV/EBITDA has dropped by -5.12 (-37.95%).
- AXSM EV/EBITDA is now -1331.54% below its all-time high of -1.30.
Performance
AXSM EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AXSM EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +4.0% | -4.0% | -3.9% |
| 1 m1 month | +2.8% | -2.8% | -2.8% |
| 3 m3 months | +5.2% | -5.2% | -5.1% |
| 6 m6 months | - | - | -2.2% |
| ytdytd | - | - | +19.2% |
| 1 y1 year | -38.0% | +21.1% | +17.3% |
| 5 y5 years | +35.9% | +79.7% | +30.4% |
AXSM EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -18.61 | at high | -20.77 | +10.4% |
| 3 m | 3-month | -18.58 | -0.2% | -21.55 | +13.6% |
| 6 m | 6-month | -17.63 | -5.6% | -24.36 | +23.6% |
| 1 y | 1-year | -12.39 | -50.2% | -24.36 | +23.6% |
| 3 y | 3-year | -10.41 | -78.8% | -27.29 | +31.8% |
| 5 y | 5-year | -6.06 | -207.1% | -31.70 | +41.3% |
| alltime | all time | -1.30 | -1331.5% | -74.77 | +75.1% |
AXSM EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -18.61(+17.2%) |
| 2023 | -15.88(-14.3%) |
| 2022 | -18.52(+64.3%) |
| 2021 | -11.27(-61.2%) |
| 2020 | -29.04(-46.2%) |
| Date | Value |
|---|---|
| 2019 | -53.94(+1966.7%) |
| 2018 | -2.61(-39.4%) |
| 2017 | -4.31(+13.7%) |
| 2016 | -3.79(-66.2%) |
| 2015 | -11.21 |
FAQ
- What is Axsome Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Axsome Therapeutics, Inc.?
- What is Axsome Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Axsome Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of AXSM is -18.61
What is the all time high EV/EBITDA for Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. all-time high EV/EBITDA is -1.30
What is Axsome Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, AXSM EV/EBITDA has changed by -5.12 (-37.95%)